Risk factors for styes include: You may have a chalazion if you have a hard lump under your skin. Chalazia develop when thick oil blocks the oil gland. You may also develop a chalazion if a stye ...

Styes and chalazia are common eyelid conditions that can cause discomfort and irritation. Understanding their causes and treatment methods is crucial for effective management. A stye, or hordeolum, ...

Unlike a stye, it doesn’t hurt but may grow large enough to affect vision. Research suggests chalazia can occur more commonly in adulthood, particularly in people aged 30-50. Xanthelasma ...

There are many causes of eye swelling or puffiness, the most common of which include allergy, a lack of sleep, eating too much sodium, or simple aging. At other times, the swelling (also known as ...

If you’ve ever encountered what looked like a pimple along your eyelid, chances are you’ve had a stye. The best way to address one is by keeping the eyelid clean and moisturized — just like ...

But two days later, she noticed a small stye forming on her eye, which worsened over the next few days. "I truly do believe it came from the tester because that was the only thing out of norm I ...

Your son's stye is also known as a chalazion or Meibomian cyst. It is a small lump on the eyelid due to a blocked oil gland, and can occur on any eyelid. Your son's eyelids contain many oil ...

As the old adage goes, “When it rains, it pours.” This is precisely the case for residents and businesses of the embattled Ditsobotla Local Municipality in the North West. Violent clashes have ...

England defeated Spain at Wembley as Jess Park’s goal secured victory for the Lionesses in the rematch of the Women’s World Cup final. Park’s finish from close range, following Alessia Russo ...

The network tests for Elden Ring Nightreign have already come and gone, which only means one thing - we're closer than ever to finally getting our hands on some co-op soulslike goodness.

A recent breakthrough in lung cancer treatment has introduced a new kinase inhibitor, Lazertinib (Lazcluze®), specifically targeting patients with non-small cell lung cancer (NSCLC) who have common ...